Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Applied Optics
|
September 11, 2019
Alignment strategy for an optomechanical image derotator using a laser Doppler vibrometer
Bettina Altmann, Tim Betker, Christian Pape, et al.
Plos One
|
March 21, 2018
Impact of different supply air and recirculating air filtration systems on stable climate, animal health, and performance of fattening pigs in a commercial pig farm
Cindy Wenke, Janina Pospiech, Tobias Reutter, et al.
Ejhaem
|
July 18, 2022
Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Karin Hohloch, Marita Ziepert, Lorenz Truemper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab
Jörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.
Annals of Hematology
|
November 26, 2020
Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's Lymphoma Study Group)
Florian Zettl, Marita Ziepert, Bettina Altmann, et al.
Leukemia
|
March 28, 2024
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial
Michael Oertel, Marita Ziepert, Fabian Frontzek, et al.
British Journal of Haematology
|
December 7, 2018
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial
Birte Friedrichs, Maike Nickelsen, Marita Ziepert, et al.
Annals of Hematology
|
September 3, 2024
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma
Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
Dominic Kaddu-Mulindwa, Bettina Altmann, Gerhard Held, et al.
The Lancet. Haematology
|
March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial
Fabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Applied Optics
|
September 11, 2019
Alignment strategy for an optomechanical image derotator using a laser Doppler vibrometer
Bettina Altmann, Tim Betker, Christian Pape, et al.
Plos One
|
March 21, 2018
Impact of different supply air and recirculating air filtration systems on stable climate, animal health, and performance of fattening pigs in a commercial pig farm
Cindy Wenke, Janina Pospiech, Tobias Reutter, et al.
Ejhaem
|
July 18, 2022
Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Karin Hohloch, Marita Ziepert, Lorenz Truemper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab
Jörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.
Annals of Hematology
|
November 26, 2020
Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's Lymphoma Study Group)
Florian Zettl, Marita Ziepert, Bettina Altmann, et al.
Leukemia
|
March 28, 2024
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial
Michael Oertel, Marita Ziepert, Fabian Frontzek, et al.
British Journal of Haematology
|
December 7, 2018
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial
Birte Friedrichs, Maike Nickelsen, Marita Ziepert, et al.
Annals of Hematology
|
September 3, 2024
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma
Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
Dominic Kaddu-Mulindwa, Bettina Altmann, Gerhard Held, et al.
The Lancet. Haematology
|
March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial
Fabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Page
of 3